Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Adverse Event Profile of USL255 in Patients with Refractory Partial-Onset Seizures: The PREVAIL Study
Epilepsy/Clinical Neurophysiology (EEG)
(-)
262
Authors/Disclosures
Robert E. Hogan, MD (Washington Univ in St Louis/Neuro Dept)
PRESENTER
Dr. Hogan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Hogan has received research support from Biogen Inc. The institution of Dr. Hogan has received research support from Engage Therapeutics. The institution of Dr. Hogan has received research support from Otsuka Pharmaceuticals. The institution of Dr. Hogan has received research support from Cerevel Therapeutics.
No disclosure on file
Toufic Fakhoury, MD (St. Joseph Neurological Assicates) Dr. Fakhoury has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB pharma. Dr. Fakhoury has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai . Dr. Fakhoury has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aquestive therapeutics. Dr. Fakhoury has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Fakhoury has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Dr. Fakhoury has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. The institution of Dr. Fakhoury has received research support from Xenon. The institution of Dr. Fakhoury has received research support from Takeda.
Bob Anders No disclosure on file
Alison Goate, PhD (WA Univ Sch of Medicine) No disclosure on file